KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

Sabra Health Care REIT (SBRA) Non Operating Investment Income (2017 - 2025)

Sabra Health Care REIT has reported Non Operating Investment Income over the past 9 years, most recently at -$9.1 million for Q4 2025.

  • For Q4 2025, Non Operating Investment Income fell 249.46% year-over-year to -$9.1 million; the TTM value through Dec 2025 reached $2.5 million, up 21.48%, while the annual FY2025 figure was -$3.5 million, 267.97% down from the prior year.
  • Non Operating Investment Income for Q4 2025 was -$9.1 million at Sabra Health Care REIT, down from -$4.4 million in the prior quarter.
  • Over five years, Non Operating Investment Income peaked at $14.1 million in Q4 2021 and troughed at -$46.5 million in Q3 2023.
  • A 5-year average of -$4.6 million and a median of -$3.8 million in 2021 define the central range for Non Operating Investment Income.
  • Biggest five-year swings in Non Operating Investment Income: soared 42581.82% in 2021 and later tumbled 58081.25% in 2023.
  • Year by year, Non Operating Investment Income stood at $14.1 million in 2021, then plummeted by 152.75% to -$7.4 million in 2022, then skyrocketed by 90.15% to -$732000.0 in 2023, then soared by 928.42% to $6.1 million in 2024, then tumbled by 249.46% to -$9.1 million in 2025.
  • Business Quant data shows Non Operating Investment Income for SBRA at -$9.1 million in Q4 2025, -$4.4 million in Q3 2025, and $10.0 million in Q2 2025.